Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Online ISSN : 1882-4528
Print ISSN : 0030-1558
Study of serum enzyme leucine aminopeptidase (LAP) isozyme in lung cancer
Tetsuo OKAZAKI
Author information
JOURNAL FREE ACCESS

1992 Volume 104 Issue 5-6 Pages 517-537

Details
Abstract
Serum leucine aminopeptidase (LAP) activity and its isozyme fraction were assayed in 73 primary lung cancer patients with the passage of time before the operation to 3 years after the operation.
The LAP activity showed a high value in 25% of the patients before the operation, but did not exhibit a significant change after the operation. By contrast, the isozyme Y fraction showed a high value in 71% of the patients before the operation and normalization was observed in half of them 1 month after the operation.
There was no significant difference in the Y fraction with the size of tumor before the operation, but a significant fall was observed after curative resection.
About half of the patients in whom the Y fraction showed a high value before the operation died within 1 year after the operation. Furthemore, the subsequent prognosis was unfavorable even in patients in whom the value was normalized after the operation, and a high Y fraction value before the operation seemed to serve as a parameter of unfavorable prognosis.
Content from these authors
© Okayama Medical Association
Previous article Next article
feedback
Top